United States | Health~Holland Country Update

Are you a Dutch LSH organization and would you like to know more about the latest LSH trends in the United States? And would you like to provide input on future activities related to the United States? Join us for this digital event to (re-)connect with key stakeholders, receive the newest LSH updates, and set the agenda for upcoming activities and initiatives for Dutch LSH organizations in the US.

When: 11 July 2024, 16:00 – 17:30 (CET)
Where: Online
For: Dutch Life Sciences & Health companies

Why?

The US is the largest market in the world when it comes to healthcare, biotech, medical devices, and the pharmaceutical industry. In 2022, the US spent US$ 4,5 trillion on medical costs, making it one of the biggest healthcare markets in the world. In the US, the availability of venture capital and the willingness to invest in technology is high. The transition from financially driven care to value-based health care offers opportunities for Dutch LSH organizations with innovative solutions that reduce healthcare costs, increase return on investment, and ensure a lower pressure on healthcare capacity.

What to expect?

During this online session, our network in the US will share the latest developments in the US market, addressing opportunities, challenges, and long-term perspectives with regards to the LSH sector. An update will be provided on the Texas Medical Center (TMC) Biobridge collaboration and the LSH Roadmap USA 2021 – 2025; a public-private trajectory focused on digitalization, accessibility, and sustainability of healthcare, as well as biopharmaceutical development. Insights and experiences of the recent LSH Trade Mission to Texas in April 2024 will be shared. We will conclude the session with an open forum to collect your input on future activities related to the United States. Together we will set the agenda for upcoming activities and initiatives that are valuable for Dutch LSH organizations with an interest in entering or scaling in the US market.

Program

The program is still under development but will be composed of the following elements:

Welcome & Opening
By Micha van Lin, Director, Task Force Health Care

LSH Roadmap USA 2021 – 2025
By Sven Walraven, Program Manager Life Sciences & Health, Netherlands Enterprise Agency (RVO)

SMM USA
By Linda van der Horst-Reijers, Program Manager Public-Private Partnerships, Netherlands Enterprise Agency (RVO)

Health~Holland USA
By Laura Duran, International Relations Manager, Health~Holland

LSH Developments and Opportunities in California / Los Angeles
By Peter Post, Director, Netherlands Business Support Office (NBSO), Los Angeles

LSH Developments and Opportunities in Minnesota / Minneapolis
By James Grizzell, Senior Policy Officer at the Consulate General of the Netherlands, Chicago

LSH Developments and Opportunities in Texas / Houston
By Stefan Theunissen, Senior Policy Officer at the Consulate General of the Netherlands, Miami

Open forum on upcoming US activities and initiatives for Dutch LSH organizations
By Daphne Elberse, Project Manager, TFHC

Wrap up & Thank you
By Micha van Lin, Director TFHC

Participation costs

Attending this Health~Holland Country Update is free of charge.

Online survey

You can help us setting the agenda for upcoming activities and initiatives for Dutch LSH organizations in the US already! Please fill out this short online survey to provide your input on future activities related to the US.

FILL IN OUR SURVEY